Stock screener

BNTC

Conviction 73HealthcareScan · Thu, Jun 25, 2026
Shooting star
BNTC$12.99-4.70%
ResistanceSupportVol 14
63 bars
Vol MA14 130.01K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Benitec Biopharma Inc.PHARMACEUTICAL PREPARATIONSwww.benitec.com
Price12.99
Change-4.70%
Gap-2.71%
Rel volume4.05×
Avg volume114.58K
Avg $ vol1.35M
SMA 2011.43
SMA 5011.89
SMA 20012.54
Price vs 50+9.27%
Price vs 200+3.57%
MA stackmixed
50/200 cross
Supertrendup · 11.01
RSI (14)63
MACD hist0.30
MACD crossbull · 8d
Stoch %K / %D71 / 85
ADX (14)21
+DI / −DI32 / 10
RSI divergenceBullish
MACD divergenceBullish
ATR %+6.15%
ADR %6.33%
52w high16.52
52w low10.06
From 52w high-21.37%
Above 52w low+29.13%
New 52w highNo
SqueezeOff
Bollinger width31.83%
%B0.93
Donchian pos70.85%
Donchian high14.22
Donchian low10.00
AVWAP (52w high)12.22
vs AVWAP high+6.33%
AVWAP (52w low)11.59
vs AVWAP low+12.13%
OBV trendFlat
Chaikin MF (20)-0.04
Today vs 20d4.05×
Avg vol (14d)130.01K
Avg vol (20d)114.58K
Avg $ vol (20d)1.35M
Market cap446.26M
RS 3m (vs SPY)+15.13%
RS 6m (vs SPY)+10.79%
RS line new highNo
Trend template4/8
Technical rank64.5
1 week+10.08%
1 month+13.45%
3 months+19.83%
6 months+5.18%
1 year-13.23%
YTD+3.22%
P/E-11.77
P/B2.43
P/S
P/FCF-18.90
EPS-1.05
Div yield
ROE-20.68%
ROA-20.28%
Debt/Eq
Current56.82
EV/EBITDA-6.27
Gross margin
Net margin
Rev growth-42.16%
EPS growth-74.32%
Price target
Target upside
Analyst rating
Institutional
Ent. value261.5M
Revenue0
Net income-11.94M
Gross profit
Free cash flow-23.61M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out34.35M
Employees19
ListedWed, Jul 11, 2012
Free float21.09M
Float %61.4%
Short interest2.33M
Days to cover30.8d
Short volume37.9%
Squeeze score62 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.24 vs −$0.27
Last surprise+11.1% beat
Setup gradeB
Conviction73 / 100
Pattern quality
Tech rank64.5 / 100
Group rank50 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmShooting star
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BNTC

All disclosures →
No recent disclosed trades by Congress in BNTC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BNTC · 1 buy

InsiderSideShares
Friedman David Matthew
Director · Options (right to buy) · 2026-05-26
Grant35K

SEC filings

EDGAR filings in BNTC

EDGAR →

No recent SEC filings on file for BNTC.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.